基本情報
- 標準SMILES
Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(I)cc1- InChIKey
BUZAJRPLUGXRAB-UHFFFAOYSA-N- 分子式
- C22H21Cl2IN4O
- 平均分子量
- 555.2 g/mol
- 単同位体質量
- 554.01371465
概要
AM-251 is a carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor. It has a role as an antidepressant, an antineoplastic agent, an apoptosis inducer and a CB1 receptor antagonist. It is a dichlorobenzene, a member of pyrazoles, a carbohydrazide, an organoiodine compound and an amidopiperidine.
名称と識別子
- 優先名称
- N-(piperidin-1-yl)-1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxamide
- IUPAC
- 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide
- 現地名
- 1-(2,4-ジクロロフェニル)-5-(4-ヨードフェニル)-4-メチル-N-(ピペリジン-1-イル)-1H-ピラゾール-3-カルボキサミド
- 英語名
- AM 251
- 分子式
- C22H21Cl2IN4O
- 分子量
- 555.24
名称と別名
名称をさらに表示
データベース識別子
- CAS
183232-66-8- PubChem CID
- 2125
- DTXSID
DTXSID7042695- ChEMBL
CHEMBL285932- ChEBI
CHEBI:90724- UNII
- 3I4FA44MAI
- EC Number
- 634-045-8
- Nikkaji
- J1.080.914B
物性
構造計算による物性
- XLogP
- 6.5
- 極性表面積
- 50.2 Ų
- 水素結合供与体数
- 1
- 水素結合受容体数
- 3
- 回転可能結合数
- 4
- 重原子数
- 30
- 形式電荷
- 0
- 複雑度
- 585
実験および物理化学的性質
物理化学的性質
- 融点
- 195 · 195-196℃
- 比重(密度)
- 1.65 · 1.65±0.1 g/cm3(Predicted)
- 貯蔵温度
- Store at RT
- 溶解性
- 10 mg/mL、可溶 · DMSO: >10 mg/mL、可溶
- 外見
- 個体
- 酸解離定数(Pka)
- 11.31 · 11.31±0.20(Predicted)
- 色
- 白い
- 安定性
- -20 °C · -20°C の DMSO またはエタノール溶液で最大 3 か月間保存できます。
- InChI
- 1S/C22H21Cl2IN4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-7-16(23)13-18(19)24)21(14)15-5-8-17(25)9-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)
- InChIKey
- BUZAJRPLUGXRAB-UHFFFAOYSA-N
- SMILES
- Cc1c(nn(-c2ccc(Cl)cc2Cl)c1-c3ccc(I)cc3)C(=O)NN4CCCCC4
- CAS データベース
- 183232 · 183232-66-8
化学的性質
化学的特性White to Off-White Solid
安全と法規制
GHS分類
GHS Classification
Warning
H315 (97.5%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 40 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
危険有害性情報
安全データ
- wgk
- 3
- hs_code
- 2933.39.6190
- risk_code
- 36/37/38
- hazard_code
- Xi
- safety_code
- 26-36
- Hazard Classifications
- Aquatic Chronic 4
- ストレージクラス
- 11 - Combustible Solids
化学と産業
応用分野
説明AM251 is a cannabinoid 1 (CB1) receptor 1 antagonist. It binds to CB1 receptors in rat forebrain membrane preparations (Ki = 7.5 nM) and is selective over CB2 receptors in mouse spleen preparations (Ki = 2,290 nM) in radioligand binding assays. AM251 inhibits GTPγS binding induced by the CB receptor agonist CP 55,940 in HEK293 cells expressing human CB1 receptors (EC50 = 8 nM). AM251 (10 mg/kg) decreases immobility time in the forced swim test in wild-type but not CB1 receptor-deficient mice. It reduces fasting-induced food intake and body weight gain in mice when administered at a dose of 30 mg/kg. AM251 also induces GTPγS binding in HEK293 cells expressing the orphan receptor GPR55 (EC50 = 39 nM) and potentiates GABA-induced GABAA receptor currents (EC50 = 0.4 μM). It prevents TGF-β1-induced epithelial-to-mesenchymal transition (EMT), inhibits SMAD2/3 and p38 MAPK activation, and reduces the expression of EMT-related transcription factors in HK-2 renal tubule epithelial cells. AM251 induces cell cycle arrest at the G2/M phase and apoptosis in A375 human melanoma cells.
使用Inhibitor of CB1 receptors. AM 251is a biarylpyrazole compound which has been considered for many years as the prototypical cannabinoid (CB) receptor antagonist
サプライヤー50 社
関連反応
現在のフィルター条件では反応記録がありません。
関連ノート
読み込み中…